Open AccessTransarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma
Author(s) -
Heung Cheol Kim,
Ki Tae Suk,
Dong Joon Kim,
JinKook Yoon,
Yeon Soo Kim,
Gwang Ho Baik,
Jin Bong Kim,
Chang Hoon Kim,
Hotaik Sung,
Jong Young Choi,
Kwang Hyub Han,
Seung Ha Park
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i3.745
Subject(s) - medicine , hepatocellular carcinoma , lipiodol , stage (stratigraphy) , gastroenterology , liver cancer , proportional hazards model , survival rate , risk factor , paleontology , biology
To evaluate the clinical characteristics of patients with Barcelona Clinic Liver Cancer (BCLC) stage 0 and A hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE).